Live Chat

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren. 76,3% der Privatanlegerkonten verlieren Geld, wenn sie mit diesem Anbieter CFDs handeln. Sie sollten überlegen, ob Sie wirklich verstehen, wie CFDs funktionieren, und ob Sie es sich leisten können, das hohe Risiko von finanziellen Verlusten einzugehen.

Close

Abbott Live-Chart

Einsichten

Weekly Search
Weekly
Daily
date Schließen change Veränderung in % Eröffnen Hoch Niedrig

Markets.com news

French election results to drive European markets
markets.com Support Team 2024 Jul 04, 21:00

Wochenausblick: Französische Wahlergebnisse entscheidend für europäische Märkte

Forex Indizes
Macron calls snap election, riles markets
markets.com Support Team 2024 Jun 29, 21:00

Wochenausblick: Frankreich als Auslöser einer Euro-Krise?

CPI
Businessman pointing hologram online banking icon.
markets.com Support Team 2024 Jun 20, 16:00

Wochenausblick: Jede Menge Daten und Inflationseinblicke

Forex Indizes
RBA, SNB, Bank of England rate decisions due next week
markets.com Support Team 2024 Jun 13, 21:00

Wochenausblick: RBA, Bank of England im Stick-or-Twist-Modus

Forex Indizes

Info

Spread

0.70

Spread (%)

0.6236 %

Hebel

1:5

Übernacht-Zinsen (Kauf)

-0.0597 %

Übernacht-Zinsen (Verkauf)

-0.0292 %

Währung

USD

Handelszeiten

Markets closed

Dienstag

14:31 - 20:59

Montag

14:31-20:59

Mittwoch

14:31-20:59

Donnerstag

14:31-20:59

Freitag

14:31-20:59

Gewinn- und Verlustrechnung

Eröffnen

---

Vorher geschlossen

---

52-Wochen-Hoch/Tief

--- – ---

Marktkapitalisierung

198266126336

Ausstehende Aktien

1734460032

Quartalsdatum (Nächstes)

2013-01-02

instr__dividend_date

2025-02-14

instr__ex_dividend_date

2025-01-15

instr__forward_annual_dividend_rate

2.36

instr__forward_annual_dividend_yield

0.0207

EPS

3.29

Ausstehende Aktien

Abbott Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Erfahren Sie mehr über dieses Instrument

Basiswert
Verkaufen
Kaufen
Veränderung in %
Ähnliche Instrumente
Trustpilot
Live Chat